Hemoglobin-based blood substitutes and risk of myocardial infarction and death

被引:5
作者
Keipert, Peter E. [1 ]
Olofsson, Christina [2 ]
Winslow, Robert M. [1 ]
机构
[1] Sangart Inc, San Diego, CA USA
[2] Karolinska Univ Hosp, Dept Anesthesiol, Stockholm, Sweden
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 300卷 / 11期
关键词
D O I
10.1001/jama.300.11.1295-b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1295 / 1296
页数:2
相关论文
共 3 条
[1]   Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death - A meta-analysis [J].
Natanson, Charles ;
Kern, Steven J. ;
Lurie, Peter ;
Banks, Steven M. ;
Wolfe, Sidney M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (19) :2304-2312
[2]   A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan®) administered to orthopaedic surgery patients with spinal anaesthesia [J].
Olofsson, C. ;
Nygards, E. B. ;
Ponzer, S. ;
Fagrell, B. ;
Przybelski, R. ;
Keipert, P. E. ;
Winslow, N. ;
Winslow, R. M. .
TRANSFUSION MEDICINE, 2008, 18 (01) :28-39
[3]   A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (Hemospan®) in patients undergoing major orthopedic surgery [J].
Olofsson, Christina ;
Ahl, Torbjorn ;
Johansson, Torsten ;
Larsson, Sune ;
Nellgard, Per ;
Ponzer, Sari ;
Fagrell, Bengt ;
Przybelski, Robert ;
Keipert, Peter ;
Winslow, Nancy ;
Winslow, Robert M. .
ANESTHESIOLOGY, 2006, 105 (06) :1153-1163